# Investigating Salt Taste Threshold in Patients Being Investigated for Primary Hyperaldosteronism Before and After Treatment.

> **NCT04556279** · — · WITHDRAWN · sponsor: **Imperial College London**

## Conditions studied

- Hyperaldosteronism; Primary
- Hypertension
- Salt; Excess
- Appetite Disorders

## Interventions

- **PROCEDURE:** adrenalectomy
- **DRUG:** Aldosterone Antagonist

## Key facts

- **NCT ID:** NCT04556279
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-01
- **Primary completion:** 2022-02
- **Final completion:** 2022-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Researcher's Decision
- **Last updated:** 2024-05-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04556279

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04556279, "Investigating Salt Taste Threshold in Patients Being Investigated for Primary Hyperaldosteronism Before and After Treatment.". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT04556279. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*